Concepedia

Publication | Open Access

Ustekinumab in Crohn's disease: real-world outcomes and predictors of response.

DOIFull Paper Access

19

Citations

10

References

2020

Year

Laura Lorenzo González, Teresa Valdés Delgado, Juan María Vázquez Morón, Luisa Castro Laria, Eduardo Leo Carnerero, María Belén Maldonado Pérez, Antonio Damián Sánchez-Capilla, Héctor Pallarés Manrique, Antonia Sáez Díaz, Federico Argüelles‐Arias
Revista Española de Enfermedades Digestivas

Abstract

ustekinumab therapy is safe and useful, inducing clinical response in more than 50 % of patients, including patients who failed with other biological therapies.

References

YearCitations

Page 1